Basel, 27 February 2018 European Commission approves Roche’s Hemlibra for people with haemophilia A with inhibitors First new medicine in over 20 years to treat people with haemophilia A with inhibitors in Europe Hemlibra demonstrated superior efficacy compared to prior treatment with bypassing agents in two phase III studies in adults, adolescents and children Once-weekly... Read more
ORLANDO, Fla., Feb. 27, 2018 /PRNewswire/ — Pittcon 2018 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled an expanded portfolio of analytical instruments, consumables, software and services to make technology more available to scientists worldwide, enabling faster, more informed decisions based on advanced scientific data. The Pittcon 2018 Conference and... Read more
MANILA, February 23, 2018 – QIAGEN N.V. today announced the opening of QIAGEN Business Services (QBS) Manila, its new Shared Service Center in the Philippines. The new location in the Cyber Sigma building in Fort Bonifacio, Taguig City, Manila, was officially opened today by Roland Sackers, Chief Financial Officer of QIAGEN, in a ceremony that... Read more
Health Canada licenses four prenatal screening assays for risk assessment of fetal trisomies and pre-eclampsia B·R·A·H·M·S Biomarkers Receive Class III Medical Device System License for Prenatal Screening WALTHAM, Mass., Feb. 15, 2018 /PRNewswire/ — B·R·A·H·M·S GmbH, a part of Thermo Fisher Scientific Inc., today announced that its sFlt-1, PlGF plus, PAPP-A and Free βhCG KRYPTOR... Read more
FRANKLIN LAKES, N.J., Feb. 15, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has completed the previously announced divestitures of its soft tissue core needle biopsy product line and Aspira® product line to Merit Medical Systems, Inc. following receipt of all required regulatory... Read more
The Scottish Cryo-EM consortium has chosen the JEOL JEM-Z300FSC CRYO ARM™ 300 as their preferred automated Cryo Transmission Electron Microscope (Cryo-TEM) for the Scottish Centre for Macromolecular Imaging (SCMI). Further information: JEOL UK press release Also See: CRYO ARM™ 200 Field Emission Cryo-electron MicroscopeCRYO ARM™ 300 Field Emission Cryo-electron Microscope # # # JEOL USA,... Read more
Hilden, Germany, and Tokyo, Japan, February 8th, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s market-leading QuantiFERON-TB technology, combining innovative... Read more
Agilent to Support Korea Doping Control Center Facility to test urine samples from thousands of athletes SANTA CLARA, Calif., Feb. 8, 2018 Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately tested to... Read more
The GE Athlete Management Solution (AMS) collects multiple kinds of data, including imaging scans, patient vitals, and venue, event and sport-specific information, and provides real-time dashboards that can help inform medical staff and allow them to personalize treatment for athletes while identifying trends in injury and illness across the Games. For example, the tool can... Read more